Financial Daily from THE HINDU group of publications
Saturday, Sep 11, 2004
News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

 Corporate - Announcements


Lupin files new drug application

Our Bureau

MUMBAI: The Mumbai-based Lupin Ltd said on Friday that it has filed an Investigational New Drug Application (INDA) with the Drug Controller General, India, for the treatment of Psoriasis, a serious skin-related problem.

This potential new drug candidate, LL-4218, is called Desoside-P, the company told the BSE. The market size of the drugs for treating psoriasis is estimated to be over $4 billion.

More Stories on : Announcements | Pharmaceuticals | Health

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Common effluent treatment plant unviable: Experts

IOC wants to build own gas pipeline
Hyundai unveils Getz at Rs 4.5 lakh
Nuts n Agro to sell dry fruits in Western region
Tentative nod for Ranbaxy drug
Lupin files new drug application
Micro Labs gets UK, SA approvals
Birla will case next hearing on Sept 14
German leather chem maker mulls making India as sourcing hub
Concept paper for curbing SEBI powers in inspecting co accounts
ITC gets Rs 803-cr excise relief
`Corporates still hungry for MBA graduates'
Vardhman Spinning to demerge textile biz
Consultant soon to advise Govt on BSNL-MTNL merger
Colgate-Palmolive setting up unit at Baddi
Diamond Interest to expand
HPCL to take part in NELP next round — To bid for ONGC's marginal fields
TVS Motors looking at Rs 100-cr exports
Matrix Labs director quits

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line